ACHC

Acadia Healthcare Company, Inc. - Q1 2025 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2025. Acadia Healthcare Company, Inc. is a leading provider of behavioral healthcare services, operating 270 facilities with approximately 12,000 beds across 39 states and Puerto Rico. The company operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), and residential treatment centers.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Decline: Net income attributable to the company dropped 89% year-over-year, from $76.4 million to $8.4 million. This was driven by a significant increase in operating expenses.
• Expense Surge: "Transaction, legal and other costs" increased to $31.1 million from $2.8 million, primarily due to $31.0 million in costs related to government investigations. Salaries, wages, and benefits rose 6.6% to $445.3 million.
• Debt Restructuring: The company refinanced its credit facility in February 2025, replacing the prior facility with a new $1.65 billion package ($1.0 billion revolving, $650 million term loan). Additionally, the company issued $550 million of 7.375% Senior Notes due 2033.
• Capital Allocation: The company repurchased $47.3 million of its own stock under a new $300 million authorization program. Capital expenditures increased significantly to $174.6 million, with $152.4 million allocated to expansion.
• Same-Facility Growth: Despite the GAAP earnings decline, same-facility revenue grew 2.1%, driven by a 2.2% increase in patient days.

Guidance, Outlook, and Risks

Management Commentary: Management highlights a tight labor market and wage inflation but notes stability in labor costs. The company continues to expand its bed count, adding 378 beds in Q1 2025. The effective tax rate increased to 32.7% from 20.3% due to lower pre-tax results and decreased equity-based compensation deductions.

Legal and Regulatory Risks:

• Government Investigations: The company is subject to ongoing investigations by the DOJ Criminal Division and the SEC regarding admissions, length of stay, and billing practices. Costs related to these investigations totaled $31.0 million in Q1 2025.
• Desert Hills Litigation: While a $400 million settlement was paid in January 2024 to resolve five cases, a sixth lawsuit was filed in January 2024. The company cannot currently estimate the liability for this new claim.
• Securities Litigation: Multiple putative class action lawsuits and derivative actions are pending, alleging violations of securities laws and fiduciary duties.

Financial Covenants: As of March 31, 2025, the company's Consolidated Total Net Leverage Ratio was 3.2x, well within the 5.0x covenant limit of its new credit agreement.

Investor Verification Checklist

• Government Investigation Costs: Verify the sustainability of the $31 million quarterly expense related to government investigations and the potential for future settlements or penalties.
• Debt Service Capacity: Assess the impact of the new 7.375% Senior Notes and increased interest rates on future cash flows and EBITDA.
• Capital Expenditure ROI: Evaluate the return on the $152.4 million in expansion capital expenditures and the timeline for new facilities to reach full capacity.
• Legal Contingencies: Monitor the status of the sixth Desert Hills lawsuit and the consolidated securities class actions for potential material liabilities.
• Labor Cost Trends: Track the trajectory of salary and wage expenses relative to revenue growth to ensure margin stability.